NCT03211143

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

A Randomized, Open-label, Multiple-dose, and Crossover Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of CKD-381 and D027 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 41 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A Study to compare Pharmacokinetics, Pharmacodynamics and safety of CKD-381 and D027 in healty subjects

Detailed description

A randomized, open-label, multiple-dose, and crossover study to compare pharmacokinetics, pharmacodynamics and safety of CKD-381 and D027 in healthy subjects

Conditions

• GERD

Interventions

Type	Name	Description
DRUG	CKD-381	Test drug: CKD-381
DRUG	Nexium	Reference drug: Nexium

Timeline

• Start date: 2017-06-20
• Primary completion: 2017-08-28
• Completion: 2017-08-28
• First posted: 2017-07-07
• Last updated: 2017-11-21

Locations

1 site across 1 country: South Korea